The prognostic value of circulating plasma cells in patients with newly diagnosed multiple myeloma was…
MDNewsline DailyOctober 13, 2023
Elranatamab demonstrated substantial and enduring responses with a favorable safety profile in patients with relapsed…
MDNewsline DailySeptember 26, 2023
A recent study found that higher side-effect bother was related to worse health-related quality of…
MDNewsline DailySeptember 26, 2023
The field of multiple myeloma (MM) treatment has seen significant advancements in recent years, which…
MDNewsline DailySeptember 18, 2023
In this exclusive MD Newsline webcast Hematology-Oncology Specialists Dr. Mouhammed Kelta and Dr. Shaina Rozell…
estherikoroSeptember 14, 2023
Question: If a hospital is not equipped to do that study, how do doctors advocate…
estherikoroSeptember 10, 2023
https://youtu.be/VNYmDOolGbs Intro: Hi everyone. My name is Shaina Rozell. I'm a hematologist-oncologist here with Affiliated…
estherikoroSeptember 10, 2023
Question: So how does multiple myeloma typically start? At which point in that journey do…
estherikoroSeptember 10, 2023
Multiple Myeloma is a type of cancer that impacts the plasma cells in the bone…
MD Newsline Content TeamAugust 21, 2023